Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

47 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The adherence to the American Association for the Study of Liver Diseases 2018 guidelines in the management of hepatocellular carcinoma and its impact on survival.
Manne A, Mulekar M, Escobar D, Prodduturvar P, Fahmawi Y, Henderson P, Abdul-Rahim O, Hussain Z, Liles S, Fonseca A, Howard JH, Mneimneh W, Gilbert R, Alkharabsheh O, Pai S, White ZB, Nelson C, Khushman M. Manne A, et al. Among authors: khushman m. J Cancer Res Ther. 2023 Jul-Sep;19(5):1103-1108. doi: 10.4103/jcrt.jcrt_1861_20. J Cancer Res Ther. 2023. PMID: 37787270 Free article.
The Prevalence of DPYD*9A(c.85T>C) Genotype and the Genotype-Phenotype Correlation in Patients with Gastrointestinal Malignancies Treated With Fluoropyrimidines: Updated Analysis.
Maharjan AS, McMillin GA, Patel GK, Awan S, Taylor WR, Pai S, Frankel AE, Nelson C, Wang B, Hosein PJ, Singh AP, Khushman M. Maharjan AS, et al. Among authors: khushman m. Clin Colorectal Cancer. 2019 Sep;18(3):e280-e286. doi: 10.1016/j.clcc.2019.04.005. Epub 2019 May 3. Clin Colorectal Cancer. 2019. PMID: 31160238
Exosomal markers (CD63 and CD9) expression and their prognostic significance using immunohistochemistry in patients with pancreatic ductal adenocarcinoma.
Khushman M, Patel GK, Laurini JA, Bhardwaj A, Roveda K, Donnell R, Sherling K, Case B, Frankel AE, Pai S, Taylor W, Tan MCB, Mizrahi M, Nelson C, Wyatt M, Patton M, McClellan S, Singh S, Wang B, Singh AP. Khushman M, et al. J Gastrointest Oncol. 2019 Aug;10(4):695-702. doi: 10.21037/jgo.2018.07.02. J Gastrointest Oncol. 2019. PMID: 31392050 Free PMC article.
Usefulness of Restaging Pelvis Magnetic Resonance Imaging After Neoadjuvant Concurrent Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer.
Fahmawi Y, Smith C, Grimm L, Khullar S, Rider P, Hunter J, Iliff G, Mneimneh W, Roveda K, Wang B, Prodduturvar P, Alkharabsheh O, McCormick B, Mizrahi M, Khushman M. Fahmawi Y, et al. Among authors: khushman m. Clin Colorectal Cancer. 2020 Dec;19(4):e281-e287. doi: 10.1016/j.clcc.2020.06.006. Epub 2020 Jun 27. Clin Colorectal Cancer. 2020. PMID: 32694005
Epidermal growth factor receptor-activating mutation(E746_T751>VP) in pancreatic ductal adenocarcinoma responds to erlotinib, followed by epidermal growth factor receptor resistance-mediating mutation (A647T): A case report and literature review.
Patel GK, Perry JB, Abdul-Rahim O, Frankel AE, Cameron D, Taylor W, Rocconi RP, Abushahin L, Nelson C, Singh AP, Khushman M. Patel GK, et al. Among authors: khushman m. J Cancer Res Ther. 2020 Jul-Sep;16(4):950-954. doi: 10.4103/jcrt.JCRT_729_18. J Cancer Res Ther. 2020. PMID: 32930150 Free article. Review.
The impact of neoadjuvant concurrent chemoradiation on exosomal markers (CD63 and CD9) expression and their prognostic significance in patients with rectal adenocarcinoma.
Khushman M, Prodduturvar P, Mneimneh W, Zotto VD, Akbar S, Grimm L, Rider P, Hunter J, Alkharabsheh O, Patel GK, Fabregas JC, Singh AP. Khushman M, et al. Oncotarget. 2021 Jul 20;12(15):1490-1498. doi: 10.18632/oncotarget.28025. eCollection 2021 Jul 20. Oncotarget. 2021. PMID: 34316329 Free PMC article.
47 results